So Far, Not So Good: Neurologists Slow to Warm Up to Biogen’s Alzheimer Drug Aduhelm, Study Finds

From: FiercePharma

By: Beth Snyder Bulik

While almost 90% of neurologists are moderately or highly aware of Aduhelm, only 3% have written prescriptions so far, according to Spherix Global Insights latest data…(read more)